PRESS RELEASE:
Their groundbreaking Level 4 Serialization Cloud platform, Adents Prodigi, allows pharmaceutical laboratories and CMOs to take advantage of the massive amount of data generated during the serialization and Track & Trace process
EAST WINDSOR, N.J. & PARIS–(BUSINESS WIRE)–October 27, 2016–
Adents, software developer for unique product identification and track & trace solutions, and Microsoft (NASDAQ:MSFT) have combined efforts to jointly develop and commercialize a new Cloud platform named Adents Prodigi. Adents Prodigi is the only Level 4 traceability solution that can centrally manage regulatory requirements imposed on the pharmaceutical industry, as well as allow laboratories and CMOs to take advantage of the massive amounts of data generated during the serialization and Track & Trace process.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161027005686/en/
Partnership between Adents & Microsoft – Christophe Devins, Adents (left) et Bernard Ourghanlian, Microsoft (right) ©Adents
Adents Prodigi opens up new horizons beyond regulatory compliance in terms of
- Unit identification and traceability
- The fight against counterfeit medicines
- OEE and productivity monitoring across production sites
- Enhanced user experience and personalized communication
- Real-time data visualization and analysis
The demand for unique product identification solutions, Adents’ area of expertise, is fueled by a global increase in regulations, for instance, in the pharmaceutical industry where more than 80% of global drug production will need to be compliant with regulations regarding unit identification by 2019. This new process offers extraordinary opportunities in terms of visibility on the life of products, but also represents a major challenge in terms of data management.
Adents Prodigi relies on advanced Microsoft Azure technologies and allows drug manufacturers to securely generate, exchange and control the huge amount of data created through unit identification. The Adents Prodigi platform also integrates data analysis (including Microsoft Power BI) and machine learning tools, providing powerful analytics capabilities for these new sources of information.
Adents Prodigi was developed collaboratively by a cross-disciplinary team of Adents and Microsoft experts, and can host business applications offered by third parties to fully exploit data stored on the platform. In total, Adents Prodigi stands as an ideal solution to ensure compliance with new regulations while efficiently mining and utilizing new data to better manage production and distribution practices.
« Our alliance with the leader of Business Intelligence will be a game changer on the global market for unit identification. Indeed, this will finally give the pharmaceutical industry the means to tap into the full potential of the wealth of information generated through serialization.” said Christophe Devins, founder and CEO of Adents.
About Microsoft:
Microsoft (NASDAQ:MSFT) is the leading platform and productivity company for the mobile-first, cloud-first world, and its mission is to empower every person and every organization on the planet to achieve more.
www.microsoft.com
About Adents:
Adents is a software developer specializing in solutions for unique product identification and track & trace helping companies from all industry sectors adapt to market changes and comply with regulations on traceability. Adents’ innovative software solutions provide brands and companies with the capacity to create and leverage the digital profile of their products, the only efficient solution to help them fight parallel markets and counterfeits, to better control their distribution channels and to create a personalized connection with their customers. Founded in 2007, Adents operates in Europe and the United States. www.adents.com – @Adentsinfo
View source version on businesswire.com: http://www.businesswire.com/news/home/20161027005686/en/
US & Europe Press Contact:
Turchette
Christopher Dale, 973.227.8080
cdale@turchette.com
@Adentsinfo
or
Adents
French Press Contact:
Laurence Zeeraerd, +33 6 15 90 86 22
presse@adents.com
@Adentsinfo